Sheikh Dr. Khalid Bin Jabor Al Thani is a globally respected leader in cancer care, prevention, and patient advocacy. As Founder and Chairman of the Qatar Cancer Society, he has spearheaded transformative initiatives to raise cancer awareness, advance early detection, and forge public–private partnerships that have improved patient outcomes across the Gulf region and beyond. He currently serves as Vice President of the International Coalition for Cancer Patients (ICPC) and Chair of its Middle Eastern Coalition, bringing together international stakeholders to close gaps in cancer care, access, and innovation. The ICPC—established more than four decades ago—is the world’s largest and oldest international cancer-fighting organization, representing over 1,180 member organizations in 172 countries.  In addition to his global advocacy work, His Excellency served as Chair of the Board of Trustees at the University of Calgary in Qatar and has held numerous senior leadership positions within Qatar’s healthcare system, including Undersecretary for the Ministry of Public Health and Vice Chairman of the National Health Authority.

In his strategic advisory role, Dr. Al Thani will work closely with BPGbio’s senior leadership and Board of Directors on global precision oncology initiatives, biology-first AI innovation, and strategic expansion in the EU, Latam, MENA, and Asia-Pac regions. He will also collaborate closely with the company’s Scientific Advisory Board to help advance BPGbio’s pipeline of programs including its lead asset, BPM 31510 for glioblastoma multiforme (GBM) trial with phase 2b readout scheduled for mid 2026, as well as other aggressive solid tumors, mitochondrial and rare diseases.